Monopar Therapeutics
SEC CIK 1645469 · MNPR · last insider filing 2026-06-30
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Sweeny Nicole | Director | filed 2026 - 2026 |
| Robinson Chandler | Director · Chief Executive Officer | filed 2018 - 2026 |
| Klausner Arthur J | Director | filed 2018 - 2025 |
| Starr Christopher M | Director | filed 2018 - 2025 |
| Tsuchimoto Kim R | Director · Chief Financial Officer | filed 2018 - 2025 |
| Anderson Raymond | Director | filed 2018 - 2025 |
| Talukdar Lavina | Director | filed 2025 - 2025 |
| Brown Michael J | Director | filed 2018 - 2025 |
| Tactic Pharma LLC | Director · Chief Scientific Officer | filed 2018 - 2025 |
| Mazar Andrew Paul | Director · Chief Scientific Officer | filed 2018 - 2025 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Cittadine Andrew | Chief Operating Officer | filed 2021 - 2026 |
| Rodriguez Susan | CCSO | filed 2026 - 2026 |
| Vu Quan Anh | Chief Financial Officer | filed 2025 - 2025 |
| Radhakrishnan Karthik | Chief Financial Officer | filed 2024 - 2024 |
| Filho Jose Octavio Pinto Costa | Chief Medical Officer | filed 2021 - 2021 |
| Anderson Kirsten | SVP, Clinical Development | filed 2018 - 2018 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.